Glioblastoma: New Immunotherapy Targets Discovered by MIT
Glioblastoma, the most aggressive form of brain cancer, has long defied effective treatment. While immunotherapy has revolutionized cancer care for many tumor types, glioblastoma has remained stubbornly resistant. Now, a groundbreaking study from MIT’s Koch Institute offers a crucial new understanding of *why* this resistance exists – and, more importantly, identifies potential pathways to overcome … Read more